Kiora Pharmaceuticals Inc. (KPRX)
NASDAQ · Healthcare
Kiora Pharmaceuticals Inc. Revenue 2015–2025
Kiora Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2015 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Kiora Pharmaceuticals Inc. revenue for the quarter ending September 30, 2025 was 0.
- Kiora Pharmaceuticals Inc. revenue for the twelve months ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Kiora Pharmaceuticals Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Kiora Pharmaceuticals Inc. annual revenue for 2024 was 16.0 M.
- Kiora Pharmaceuticals Inc. annual revenue for 2023 was 0.
- Kiora Pharmaceuticals Inc. annual revenue for 2021 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kiora Pharmaceuticals Inc. (KPRX) — Frequently Asked Questions
Kiora Pharmaceuticals Inc. (KPRX) is a publicly traded US company. It has a market capitalization of $11M. Explore KPRX's stock price, financial statements, earnings history, margins and key ratios below.
What is Kiora Pharmaceuticals Inc.'s market cap?
Kiora Pharmaceuticals Inc. (KPRX) has a market capitalization of $11M.
What is the KPRX stock price?
KPRX trades at $2.67 (+1.52% on the day).
Is KPRX profitable?
In fiscal 2025, Kiora Pharmaceuticals Inc. reported net income of -$11M.